{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:37:10Z","timestamp":1791221830953,"version":"4.1.0"},"reference-count":25,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hantaviruses are tri-segmented lipid-enveloped RNA viruses belonging to the Bunyaviridae family. Human infection corresponds to a zoonosis associated with two different clinical syndromes: hemorrhagic fever with renal syndrome that occurs in Asia and Europe and hantavirus cardiopulmonary syndrome (HCPS) that occurs in the North America, Central America and South America. The major pathogenic mechanisms in HCPS include (1) direct microvascular endothelial injury leading to increased capillary permeability and the development of noncardiogenic pulmonary edema and acute respiratory distress syndrome, and (2) exaggerated host immune response leading to secondary organ damage. The incubation period for this disease is quite long (6\u201339 days, median: 18 days); however, rapid progression to respiratory failure and shock can occur highlighting the importance of high index of clinical suspicion. Management revolves around high-quality supportive care. Various management and preventative strategies are currently being explored and warrant further examination to improve the overall outlook following infection with hantavirus.<\/jats:p>","DOI":"10.1055\/s-0041-1733803","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T01:09:12Z","timestamp":1639703352000},"page":"822-827","source":"Crossref","is-referenced-by-count":7,"title":["Hantavirus"],"prefix":"10.1055","volume":"42","author":[{"given":"Ra\u00fal","family":"Riquelme","sequence":"additional","affiliation":[{"name":"Puerto Montt Hospital, San Sebastian University, Puerto Montt, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/infdis\/137.3.298","article-title":"Isolation of the etiologic agent of Korean hemorrhagic fever","volume":"137","author":"H W Lee","year":"1978","journal-title":"J Infect Dis"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3201\/eid0302.970202","article-title":"Hantaviruses: a global disease problem","volume":"3","author":"C Schmaljohn","year":"1997","journal-title":"Emerg Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1126\/science.8235615","article-title":"Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness","volume":"262","author":"S T Nichol","year":"1993","journal-title":"Science"},{"issue":"02","key":"ref4","first-page":"169","article-title":"[Hantavirus pulmonary syndrome: current situation among rodent reservoirs and human population in the 10th region, Chile]","volume":"131","author":"R Mur\u00faa","year":"2003","journal-title":"Rev Med Chil"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jcv.2014.08.033","article-title":"Hantaviruses-globally emerging pathogens","volume":"64","author":"D H Kruger","year":"2015","journal-title":"J Clin Virol"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/viro.1997.8976","article-title":"Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus","volume":"241","author":"P J Padula","year":"1998","journal-title":"Virology"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3201\/eid2010.140353","article-title":"Person-to-person household and nosocomial transmission of Andes hantavirus, Southern Chile, 2011","volume":"20","author":"C Mart\u00ednez-Valdebenito","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"04","key":"ref8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3201\/eid2604.190799","article-title":"Person-to-person transmission of Andes Virus in hantavirus pulmonary syndrome, Argentina, 2014","volume":"26","author":"D O Alonso","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/516786","article-title":"Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in chile","volume":"195","author":"M Ferres","year":"2007","journal-title":"J Infect Dis"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3201\/eid2104.141437","article-title":"Hantavirus pulmonary syndrome, Southern Chile, 1995-2012","volume":"21","author":"R Riquelme","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.virusres.2014.01.015","article-title":"Hantaviruses and cardiopulmonary syndrome in South America","volume":"187","author":"L TM Figueiredo","year":"2014","journal-title":"Virus Res"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1086\/513874","article-title":"Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome","volume":"195","author":"F P Saggioro","year":"2007","journal-title":"J Infect Dis"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3201\/eid0911.020798","article-title":"Hantavirus pulmonary syndrome, southern Chile","volume":"9","author":"R Riquelme","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3201\/eid0505.990512","article-title":"Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States","volume":"5","author":"P T Kitsutani","year":"1999","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.4067\/S0034-98871999001200015","article-title":"Hantavirus en Chile: revisi\u00f3n y an\u00e1lisis de casos desde 1975","volume":"127","author":"M Bar\u00f3","year":"1999","journal-title":"Rev Med Chil"},{"key":"ref16","volume-title":"Gu\u00eda cl\u00ednica de prevenci\u00f3n, diagn\u00f3stico y tratamiento del s\u00edndrome cardiopulmonar por hantavirus"},{"issue":"06","key":"ref17","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.ejcts.2011.01.089","article-title":"Extracorporeal membrane oxygenation support improves survival of patients with Hantavirus cardiopulmonary syndrome refractory to medical treatment","volume":"40","author":"J A Wernly","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.virusres.2011.09.017","article-title":"Hantavirus pulmonary syndrome","volume":"162","author":"A Macneil","year":"2011","journal-title":"Virus Res"},{"issue":"06","key":"ref19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/infdis\/164.6.1119","article-title":"Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome","volume":"164","author":"J W Huggins","year":"1991","journal-title":"J Infect Dis"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/135965359900400404","article-title":"Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience","volume":"4","author":"L E Chapman","year":"1999","journal-title":"Antivir Ther"},{"issue":"09","key":"ref21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/425007","article-title":"Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America","volume":"39","author":"G J Mertz","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"07","key":"ref22","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cit394","article-title":"High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial","volume":"57","author":"P A Vial","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3851\/IMP2875","article-title":"A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus","volume":"20","author":"P A Vial","year":"2015","journal-title":"Antivir Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.3389\/fmicb.2019.02989","article-title":"Vaccines and therapeutics against hantaviruses","volume":"10","author":"R Liu","year":"2020","journal-title":"Front Microbiol"},{"issue":"468","key":"ref25","doi-asserted-by":"crossref","first-page":"eaat6420","DOI":"10.1126\/scitranslmed.aat6420","article-title":"Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo","volume":"10","author":"J L Garrido","year":"2018","journal-title":"Sci Transl Med"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1733803.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T23:03:32Z","timestamp":1674083012000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1733803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":25,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2021,12,16]]},"published-print":{"date-parts":[[2021,12]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1733803","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}